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A COMPOUND far less toxic than nitrogen mustard is obtained by linking the
chloroethylamino radical to a sugar molecule, particularly a mannitol molecule
(BCM, Degranol, 1:6-bis) (,8-chloroethylamino)-1:6-desoxy-D-mannitol dihydro-
chloride) (Vargha, 1955; Vargha, Toldy, Feher and Lendvai, 1957; Kellner
and N6meth, 1956). Hungarian workers have long ago entertained the idea that
if instead of the chloroethylamino radical the sulphonoxyd radical is bound to
mannitol the result must be a compound of lesser toxicity than Myleran. At the
London Congress of 1958, and later in a preliminary communication, Haddow,
Timmis and Brown (1958) reported the preparation of this compound and its
effects on the Walker rat carcinoma-256, the "August" rat carcinoma, and a
radiation-induced rat leukaemia. In work based on the earlier Hungarian con-
ception and running parallel with the efforts of the English authors, Vargha
and Kuszmann (1959) also prepared 1:6-dimethane-sulphonyl-D-mannitol (here-
after referred to as MM), but by a different route. Their compound was submitted
to us in September 1958 to determine its biological properties.
Our findings to date show MM to possess excellent toxicological and pharma-
cological properties. It exerts a marked effect on the blood picture, inhibits the
growth ofvarious different transplantable tumours, heavily damaging the tumour
cells and altering the tissue structure in its entirety and gives rise to distinct
morphological changes in organs (bone marrow, duodenum, spleen, testes).
Unlike Myleran, MM is readily soluble in water. This explains why the two
compounds differ in biological properties. It is much less toxic than Myleran,
and this is a quality of deep importance (Table I). Soon after it is dissolved in
water the pH signifies acidity when, on the evidence of data obtained in tissue
culture, its destructive effect on tumour cells decreases, though it does not cease
altogether. Minimum lethal doses of it kill experimental animals in four or five
days, but if administered in fractions death occurs as late as in 14 to 20 days.
Owing to the marked cumulative effect of the drug, tests to determine the LD5so
must be carried onfor at leastfourweeks, notinfrequentlyfor 60days, occasionally
for a still longer period oftime.
In animals which died from acute MM poisoning, autopsy showed the intestines
to be inflated with fluid, the mucous membrane to be hyperaemic, with extensive
haemorrhages on both the mucosa and serosa; the spleen was remarkably wasted;
the lungs were oedematous, with haemorrhagic spots in them; transudate
accumulated in the body cavities; the bone marrow was vividly red, and after
a more than usually large dose, slightly jellied.
Certain observations have been made which, though requiring further studies
and detailed confirmation, show that some considerable time after the introductionB. KELLNER AND L. NEMETH
of a larger dose of MM grave lesions may arise in the organism (abscesses on the
skin, decubituses on the extremities, emaciation, exsiccosis, pneumonia, tubercu-
losis, etc.), with tumour-formation in some cases (leukemia, sarcoma, hypophysis
tumour, etc.).
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FIG. 1.-Effect of MM on the W.B.C. of rats.
TABLE I.-Pharmacological DataDeterminedfor MM
(Observationperiod: 30 days)
For the mouse'
For the rat2
For the rabbit .
LDloo
For the mouse
For the rat
For the mouse
For the rat
For Ehrlich ascites t
For resistant solid ti
For sensitive solid ti
Minimum effective dose (determined
by changes in the blood picture of
the rat)
Cumulative action
C3 strain.
2Chester Beatty strain.
3 Given on one occasion.
4 Given for seven consecutive days.
5Mortality of mice.
8 Per cent body weight change on the 4th day (rat).
4 300 i.p.
2-900 i.p.
2 -000 i.p.
11500 i.v.
and i.p.
tumour . . 200 i.p.
amour (Crocker) . 500 i.p.
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In 24 to 48 hours following the injection of a relatively small dose, the first
to decrease in number were the neutrophil granulocytes in the blood stream:
one tenth ofthe maximum tolerated dose, or 50 mg./kg., reduced their number by
20 to 50 per cent in the rat and the rabbit. In the leukocyte count, on the action
of this dose the maximum decrease usually presented itself on the fourth day
(Fig. 1), and was soon followed by a compensating leukocytosis lasting for about
three weeks (Table II). The lymphocytes were left unaffected by a similar dose;
TABLE II.-Changes in the Blood Picture of the Rabbit due to the Action of MM.
100 mg./kg. i.v. 200 i.v. 300 i.v. 500 oral
W.B.C. Ne Ly R.B.C. W.B.C. N L R.B.C. W.B.C. N L R.B.C. W.B.C. N L R.B.C.
Days 103 103 103 106 10 osl0s10 106 103 106 103 106 103 106
3.9 5.0 . 4-6 0-9 3-7 5-6 . 4-6 1-4 3-2 .. . 6-3 1-3 5-0 5-6
3-2
3-1
2-9
3.5
3.5
1-8
3-2
5.5
4.7
5- 1
4 0
4-6
4-2
6-6
5-2
4-6
4.3
2-3
7-2
5.9
1-8
1-6
0 5
0 5
0 3
1-6
0.9
4-8
3-6
4- 1
3-8
2-0
5-6
5.0
5-2
5-8
5-8
5.4
5.2
4.0
4.4
. 3-8
. 6-6
. 3-8 .38
. 6-2
. 4-8
. 6-8
1.0
0-8
0 4
0.15
3-8
0.5
1.4
3.4
3 0
6-2
3-65
2-4
4.3
5.4
5.6
4.7
4-6
5 0
5.2
4.9
3-8
5.9
9-6
9.3
2-8
..... .~~~~- . 4-2 - - 5-2
Exitus
09 40
0-6 3-2
0-3 5-6
1-4 8-2
1-4 7- 9
Exitus
5.4
5-2
3-8
4-2
5 0
5-6
1000 oral 2000 oral 3000 oral 5 x 200 i.v.
W.B.C. N L R.B.C. W.B.C. N L R.B.C. W.B.C. N L R.B.C. W.B.C. N L R.B.C
Days 103 103 103 106 103 103 103 106 103 103 103 106 103 103 103 106
efore . 9-6 6-7 2-9 5-2 . 12-0 4-8 7-2 5-2 5.7 0-8 4.9 5-6 6-8 2-4 4-4 5-2
2-3
1-3
2-7
3-1
7.5
3.8
3-6
2-4
5-6
5.0
4-2
4.4
8-6
9.9 4-8 5-1 5-6
2-8 0.05 2-75 5.0
11-3 5-65 5-65 4-6
13-3 7-3 6-0 5-2
9.5 4.75 4.75 5.0
Exitus
5.5
4-0
2-1
2-2 3.3
1-8 2-2
0. 01 2-09
Exitus
5-2
4-8 .
.
2-1
2-1
2-3
0 9
1-7
4-8
0-8 1-3
0 5 1-6
0 5 1-8
0-1 0-8
0-2 1.5
2-3 2-.5
5-2
4-8
4-2
5.1 1-2
4-2
3.8
3.4
3.9
3.7
2-5
3-8
Before
treatment
1
2
3
4
5
6
7
9
11
12
14
16
18
21
29
50
56
74
1.0
0 7
0.5
0 4
0-2
0 7
0.6
B
7.7
6-4
1-5
1.1
3.5
8-9
10-8
8-3
treatment
I .
9
3
4
5
6
7
9
11
12
14
16
18
21
29
50
56
74
10.0
7.7
4-2
4-2
11.*0
12-7
14-4
10-7
18-0
Exitus
471
I
=B. KELLNER AND L. NEMETH
for them to decrease in number a dose was required which was capable ofreducing
the number of neutrophils by more than 50 per cent; even then, a relative
lymphocytosis sometimes developed owing to the high degree of neutropenia.
The thrombocyte count remained the same unless the drug was introduced in
a quantity approaching the median lethal dose. Erythropoiesis was left intact
even by that dose, but a lethal dose gave rise to haematologic changes resembling
grave agranulocytosis, and red blood corpuscles began to be destroyed upon its
action.
When the doses were administered in fractions, the changes in the blood
picture were much more conspicuous.
In the bone marrow, smaller doses induced no particularly remarkable lesions
in the mouse and the rabbit, although the bone marrow of the latter was slightly
more sensitive. Doses of the drug approaching the maximally tolerated level
produced significant reductions in the number of myeloid elements, but left the
erythropoietic cells, the megakaryocytes and the reticular elements undamaged.
Quantities in excess of the maximum tolerated dose gave rise to grave changes
in the bone marrow, causing pycnotic disintegration of large numbers of cells and
reducing the number of cells of intact structure; the capillaries among them
appeared dilated, and the remaining megakaryocytes become all the more con-
spicuous. Treatment even with large doses given for a long period of time failed
to reveal changes pointing to serious lesions in erythropoiesis.
The tumour-inhibiting action of the drug is apparently selective: it differed,
in fair degree in the six tumour types involved in our tests (Yoshida rat sarcoma,
Guerin rat carcinoma, Ehrlich adenocarcinoma, Crocker sarcoma 180 in mice
and the 36th passage of ENG spontaneous sarcoma in mice) (Table III). This
obviously makes it desirable to test the compound against a wider spectrum of
tumours for its growth-inhibiting activity.
TABLE III.-Growth Inhibiting Action of MM on Transplanted Tumours
Type of Number of Dose Percentage
tumours animals (mg./kg./day) inhibition
Yoshida solid . . . 5 x 500 i.v. . 77
Killed on 6th day
Gu6rin . . . . 10 . 9 x 500 i.v. 95
Killed on 10th day
Crocker .. . . 10 . 10 x 500 i.p. 52
Killed on 11th day
ENG mouse-sarcoma . 10 5 x 500 i.p. 87
Killed on 6th day
Ehrlich ascites . . 10 . 6 x 200 i.p. . 36
Killed on 8th day
Ehrlich subcutaneous . 10 . 6 x 500 i.p. 30
Killed on 8th day
Generally speaking, MM has a more marked inhibitory effect on transplanted
tumours of the rat than on those of the mouse. A fact meriting special attention
is that on the Gu6rin tumour, known to be fairly resistant to most drugs ofthera-
peutic effect, as much as 90 per cent inhibition of growth was seen, and on the
intravenous administration of a very large quantity (9-10 x 500 mg./kg.), even
recovery was attained. A much smaller amount of the drug sufficed to bring
about recovery in Yoshida tumour.
The question of how MM affects survival has not yet been fully investigated.
472EFFECT OF 1: 6-DIMETHANE-SULPHONYL-D-MANNITOL
Nevertheless, on the strength of experience that has been gained so far, it seems
safe to say that, given in suitable doses, the compound is capable not only of
retarding growth, but also ofprotracting survival time.
In tissue culture, MM was observed to have growth-inhibitory and destructive
effects on fibroblasts of chick-embryo hearts and fresh Crocker sarcoma and
HeLa cells. Cultures incubated for 24 hours were treated with solutions ofvarious
concentrations ofthe drug, and after an additional 24 hours the extent ofdamage
was evaluated, and expressed by i, +, + +, or ++. After adding sodium
bicarbonate, to bring the pH from acid to neutral, a 1000 y/ml. dose was enough
to elicit a very marked effect, while double this dose was found to destroy all
the cultures. With a solution which had not been treated to prevent a fall in
pH (pH 5-8), a dose ofas much as 5000 y/ml. was required for the drug to exercise
its maximum effect (Table IV). It is remarkable how nearly the doses found
efficaceous in explants, agree with those established in our experiments in vivo.
This seems to indicate that explantation might be of value in determining the
doses.
TABLE IV.-Effect of MM on Tissue Culture
Fibroblast Crocker HeLa
Gamma/mi. 1 2 1 2 1 2
250 . .. + . +
500 . +± + + +
1000 . . +++ + +-++- +(+) ++--
2000 . . + ++ + +++ *-
5000 . .. + 4(+) . .. + . .. ..
1. pH: 7'0.
2. pH: 5-8.
In Ehrlich ascites tumour, MM-like chemotherapeutic agents in general-
produced a reduction in the cell count, an increase in the number of eosinophils,
and caused changes in cellular morphology and acridine-orange uptake. It is
interesting to note that whereas after the introduction of most agents (chloro-
ethylamino derivatives, antimetabolites, etc.) acridine-orange uptake decreases,
it invariably increased upon the action of MM, quite like upon that of Myleran
(Table V).
TABLE V.-Changes in Number and Staining Capacity of Ehrlich
Ascites Cells Following Treatment of MM
MM 500 mg./kg. intraperitoneal
,_ -
6 24 48 72 96
Controls Hours
(%) ,
Number of cells* 100 51 36 39 30 16
Cells staining with eosint . 5 8 16 37 29 40
Acridin orange-uptake: . 100 89 223 273 219
* 105/ml. = 100 per cent.
t In percentage of total cells.
t 10-8 gamma/cell -= 100 per cent.
Similarly to Degranol and several other chemotherapeutic drugs, MM prevents
many of the intravenously introduced tumour cells from taking, and inhibits
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metastasis production. Twenty-four hours after the intravenous introduction of
ten million Guerin carcinoma cells, each of a group of five animals was given into
the veins seven consecutive daily doses of 500 mg. of MM, and another group was
left untreated to serve as controls. All were sacrificed on the 24th day following
transplantation. Autopsy revealed extensive metastases in the lungs, adrenals.
and lymph nodes of the controls, but none in four of the treated experimentals.
while in the fifth, only a few metastases were found, restricted to lymph nodes
(Fig. 2). We regard this protective action ofMM as significant since on the evidence
of our earlier findings (Lapis and Nemeth, 1956) Myleran does not possess it:
in addition, it may prove to be of value before and after surgical treatment of
tumours.
Fic. 2.-Effect ofMM on the metastasis of intravenously induced Gu6rin carcinoma as observed
on the 20th day.
In our studies of the dynamics of the morphological changes caused by MM,.
Guerin tumours were chosen: first, because the cells in their viable parts are
fairly uniform; secondly, because in Guerin tumours of roughly equal size. the
proportion of the area of the viable parts to that of the circumscribed necrotic
parts of moderate extent, is largely the same; and thirdly, because MM power-
fully inhibits the growth of this type of tumour. About ten days after tranls-
plantation, animals bearing tumours the size of a small walnut were selected and
given intravenously a single 2000 mg./kg. dose of MM. These were killed one by
one, 1, 3, 6, 10, and 12 hours, 1, 2, 3, 4, and 5 days, after injection. Sections were
prepared of the tumours at the largest diameter, and of the more importalnt
organs. The morphological changes seen were essentially the same as those
produced by the other alkylating agents (nitrogen mustard, Degranol, Sarcolysin,
Mitomen, etc.). We describe them in the following (Table VI).
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TABLE VI.-Cytological Changes Upon the Action of MM
Found in tumour
Hours after administration
Control --'
10 24 48 72 92 120
Intact cells . 6-7 . 0-8 0-2 0.1 - -
Mitosis, anomalous or disin- 1 2 . 7- 5 15 26- 7 22 4 6- 4 9 6
tegrating
Bi- and multinuclear cells . 3-6 3-8 17 - 7 404 78-6 47-5 49- 3
Necrosis . -- +- ++- ++ ++ -+++ ++++ ++++----
Assayed in duodenum
Decrease in number ofmitotic + +++ +-+--+ + + + +-- -+-
cells
Anomalous mitotic cells . - +- + + - - - - - +
Disintegrating mitotic cells. -. + + + + +-+ + - -
Resting cells . - . - + +- - + + + + + + +-
Giant cells . .. . .. .. .. +-- +..
+- From sporadic to few.
-+ +- From few to about half.
+ + + From half to many.
++ + Between many and almost all.
After 12 hours, only cells in the process of mitosis are affected: the chromatin
is loosened in structure or reduced to powder, the chromosomes have drifted
away and broken into fragments, a bridge is formed between the two mitotic
spindles, etc. After one day, but more conspicuously so after two days, anomalous
mitoses increase in number, pycnotic nuclear destruction sets in, and binuclear
and multinuclear cells suddenly appear. Thereafter, anomalous mitoses decrease
in number, and pycnotic disintegration becomes so extensive within the viable
parts as to loosen the structure of the tumour. The central necrotic areas keep
growing in size until on the 4th or 5th day the entire tumour is but a necrotic
mass, with only a very thin envelope ofretained tumour tissue around it, in which
most of the tumour cells, showing two or more nuclei are seen surrounded by
an increasing number of connective tissue fibres (Fig. 3 and 4).
In the duodenum, mitoses were no longer seen after 10 hours, but pycnotic
nuclei were encountered in very large numbers. By the third day, the villi were
broadened and flattened, their connective tissue was extensively infiltrated by
globular cells, there was cystic dilatation of the glands, and the epithelial cells
were flattened or turned into multinuclear giant cells. By the fifth day, hardly
any traces of these changes were seen (Fig. 5).
Morphological changes of the above description-enlargement of the necrotic
areas, mitotic anomalies, and pycnotic disintegration of tumour cells-are seen
in Crocker 180 mouse carcinoma and ENG mouse sarcoma, but they are of a much
milder nature and require considerably larger doses to arise (3 to 6000 mg./kg.).
SUMMARY
The compound prepared by linking the sulphonoxyd radical with mannitol
is readily soluble in water, much less toxic than Myleran, and possesses superior
biological qualities.
In tissue culture, on the use of a neutral medium it exercises a powerful
destructive effect on fibroblasts, and Crocker and HeLa cells.
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It is capable of potentially damaging Ehrlich ascites cells, as is evidenced by
a decrease in their number upon its action, and an increase in their capacity to
stain with eosin and acridine orange.
One tenth of the maximally tolerated dose of the compound suffices to give
rise to marked changes in the blood picture; the granulocytes in the blood
stream and the myeloid elements of the bone marrow suffer most. Lymphocytes
are left unaffected by doses ofless than at least a 50 per cent neutrophil-depressing
activity. Toxic doses are required to do damage to thrombocytes. The least
effect the compound has is that on the erythropoietic system.
In six different types of rat and mouse tumours its growth-inhibiting action was
found to range from 30 to 90 per cent. Recoveries were attained with it in Yoshida
and Guerin tumours. Unlike Myleran, it inhibited metastatic diffusion to the
organs after intravenous transplantation.
Its destructive effect on tumour cells, studied chiefly in Guerin rat carcinoma,
is similar to but more lasting than that of the other alkylating agents.
Preliminary data obtained in as yet incomplete investigations indicate that
the compound may possess a cumulative effect and a carcinogenic action which
manifests itself early (mouse leukaemias, endotheliomas associated with ascites,
etc.).
Our thanks are due to Dr. Martha Schmidt and Dr. Ibolya Fogarassy for divers
laboratory tests carried out with rabbit blood; to Dr. J. Sugar and Dr. Eva Gati
for investigations into the straining capacity of ascites tumours; to I. Palyi and
Emily Greczy for tissue culture experiments; and to G. Galffy for his assistance
in our toxicological and biological studies.
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EXPLANATION OF PLATES
FIG. 3.-Morphological changes in Guerin rat carcinoma due to the action of MM:
(a) Controls. Viable portion. x 200.
(b) Picture seen 60 hours after injection of a single dose of 2000 mg./kg. dose. Note
extensive pycnotic nuclear disintegration, loosened structure, and the presence of cells with
two and more nuclei. x 200.
(c) Picture seen 120 hours after injection ofthe same dose. Note that most ofthe cells are
now bi- or multinuclear and that there are now more connective tissue fibres. x 200.
FIG. 4.-(a) Great number ofanomalous mitotic forms and disintegrating cells. Chromatin in
resting cells clumped or of a lytic light colour. (Identical with Fig. 3b but x 1620.)
(b) Giant cells and increased amount of connective tissue. (Identical with Fig. 3c but
x 1620.)
FIG. 5.-Pictures of the duodenum seen after administration of a single dose of 2000 mg./kg.
(a) Ten hours after injection: mitoses no longer visible; numerous pycnotic nuclei and
chromatin globules formed from nuclear fragments; most cells at rest turned light in colour;
great number of goblet cells. x 220.
(b) Seventy-two hours after injection: duodenal mucous membrane very thin; villi
broadened; glands dilated cystlike; epithelial lining flattened; infiltration ofglobular cells
in connective tissue extending as far as the submucosa.BRITISH JOURNAL OF CANCER.
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